3D-Printed Intravaginal Ring Platform
Women's Health (Multiple Potential Indications)
Pre-clinicalActive
Key Facts
Indication
Women's Health (Multiple Potential Indications)
Phase
Pre-clinical
Status
Active
Company
About AnelleO
AnelleO is a private, pre-revenue biotech founded in 2017, focusing on advanced drug-device combinations for women's health. Its core innovation is a proprietary 3D printing platform, utilizing Digital Light Synthesis (DLS) from Carbon, Inc., to manufacture geometrically complex IVRs with precise control over drug release kinetics for small and large molecules. The company is positioned as a potential partner for pharmaceutical companies seeking to enhance or enable new therapies through its rapid, scalable, and tunable delivery platform, targeting a significant gap in the women's health market.
View full company profile